In Situ Hybridization Market by Product (Consumables, Instruments, Software), Technology (Chromogenic In Situ Hybridization, Fluorescence In Situ Hybridization), Application, End User - Global Forecast 2024-2030

In Situ Hybridization Market by Product (Consumables, Instruments, Software), Technology (Chromogenic In Situ Hybridization, Fluorescence In Situ Hybridization), Application, End User - Global Forecast 2024-2030

The In Situ Hybridization Market size was estimated at USD 1.81 billion in 2023 and expected to reach USD 1.94 billion in 2024, at a CAGR 7.92% to reach USD 3.10 billion by 2030.

Global In Situ Hybridization Market In-situ hybridization is a process utilized to identify and detect specific DNA sequences in cells with an increasing number of unknown viruses. In-situ hybridization allows precise localization of a specific nucleic acid segment within a histologic section. It is a major laboratory technique used to localize an RNA or DNA sequence in a biological sample. The prevalence of chronic diseases and the need for rapid diagnostic techniques contribute to the increasing adoption of in-situ hybridization. Cancer was among the leading cause of death in 2020, with approximately 100 million deaths worldwide. Growing demand for molecular diagnostic tools and advancements in the field of IVD is anticipated to boost the adoption of in-situ hybridization (ISH) technology in the coming years. High costs and limited skilled professionals for managing in-situ hybridization hamper the adoption of in-situ hybridization. However, the ongoing technological advancements and increasing research and development (R&D) to introduce innovative in-situ hybridizations are expected to create opportunities for the growth of the in-situ hybridization market.Regional InsightsThe presence of technologically upgraded infrastructure in the U.S., Canada, and Brazil is increasing the adoption of ISH, which enables early diagnosis of diseases. Furthermore, key players in the In Situ Hybridization (ISH) market and the launch of innovative products in the region are expected to fuel the In Situ Hybridization (ISH) industry growth in the Americas. In December 2022, OmicsVeu launched an extensive line of spatial biology products, mRNA and DNA FISH probes, and kits. A wide range of over 220 plus fluorophore-tagged miRNA probes enables the generation of multiplex miRNA profiling. Increasing investments in R&D pertaining to IVD in Europe driving the adoption of in situ hybridization (ISH) market. The presence of government organizations in the region, including the European Diagnostic Manufacturers Association (EDMA), which focuses on the development and overall growth of the European IVD industry, is contributing to the growth of the ISH market in Europe.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the In Situ Hybridization Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the In Situ Hybridization Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the In Situ Hybridization Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abcam Plc, Abnova Corporation, Advanced Cell Diagnostics, Inc., Agilent Technologies, Inc., Bio SB, Bio-Rad Laboratories, Inc., Biocare Medical, LLC, BioCat GmbH, Bioevopeak Co., Ltd. |, BioGenex Laboratories, Biomers.net GmbH, BioView Ltd., Cell Line Genetics, Inc., CellCarta Biosciences Inc., Charles River Laboratories International, Inc., CiteAb Ltd., Cole-Parmer Instrument Company, LLC., Creative Bioarray, Creative Biolabs, Daicel Arbor Biosciences, DSS Imagetech Pvt. Ltd., Emsurg Healthcare (India) Pvt. Limited, Enzo Life Sciences, Inc., Excilone, F. Hoffmann-La Roche Ltd, Flogentec, GeneDetect.com Limited, Intertek Group PLC, KromaTiD Inc., Leica Biosystems Nussloch GmbH, Merck KGaA, Molecular Instruments, Inc., NeoGenomics Laboratories, Inc., Okabé Bureau, Opgen, Oxford Gene Technology IP Limited, PerkinElmer Inc., Qiagen N.V., QIMA Life Sciences, Reveal Biosciences, Inc., Ribocon GmbH, Spatial Genomics, Inc., Stratech Scientific Ltd, Suraksha Diagnostic Private Limited, Thermo Fisher Scientific Inc., Vector Laboratories, Inc., Zytomed Systems GmbH, and ZytoVision GmbH.

Market Segmentation & Coverage

This research report categorizes the In Situ Hybridization Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Consumables
Accessories

Kits & Reagents

Probes

Instruments

Software

Technology
Chromogenic In Situ Hybridization

Fluorescence In Situ Hybridization
DNA Fluorescence In Situ Hybridization

PNA Fluorescence In Situ Hybridization

RNA Fluorescence In Situ Hybridization

Application
Cancer Diagnostics

Cytology

Immunology

Infectious Disease Diagnostics

Neuroscience

End User
Academic & Research Institutes

Contract Research Organizations

Hospital & Diagnostic Laboratories

Pharmaceutical & Biotechnology Companies

Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas

Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam

Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the In Situ Hybridization Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the In Situ Hybridization Market?
3. What are the technology trends and regulatory frameworks in the In Situ Hybridization Market?
4. What is the market share of the leading vendors in the In Situ Hybridization Market?
5. Which modes and strategic moves are suitable for entering the In Situ Hybridization Market?

Note: PDF & Excel + Online Access - 1 Year